Alloreactive T cells are core mediators of graft rejection and are a potent barrier to transplantation tolerance. It was previously unclear how T cells educated in the recipient thymus could recognize allogeneic HLA molecules. Recently it was shown that both naïve and memory CD4+ and CD8+ T cells are frequently cross-reactive against allogeneic HLA molecules and that this allorecognition exhibits exquisite peptide and HLA specificity and is dependent on both public and private specificities of the T cell receptor. In this review we highlight new insights gained into the immunogenetics of allorecognition, with particular emphasis on how viral infection and vaccination may specifically activate allo-HLA reactive T cells. We also briefly discuss the potential for virus-specific T cell infusions to produce GvHD. The progress made in understanding the molecular basis of allograft rejection will hopefully be translated into improved allograft function and/or survival, and eventually tolerance induction. © 2011 The Author(s).
CITATION STYLE
D’Orsogna, L. J., Roelen, D. L., Doxiadis, I. I. N., & Claas, F. H. J. (2012, February). TCR cross-reactivity and allorecognition: New insights into the immunogenetics of allorecognition. Immunogenetics. https://doi.org/10.1007/s00251-011-0590-0
Mendeley helps you to discover research relevant for your work.